Medicare Enrolled
Dr. Daniel Navi, M.D.
Dermatology · Palo Alto, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Navi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Navi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Navi
Dr. Daniel Navi is a dermatology specialist in Palo Alto, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Navi performed 3,638 Medicare services across 1,982 unique beneficiaries.
Between the years covered by Open Payments, Dr. Navi received a total of $16,802 from 45 pharmaceutical and/or device companies across 813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Navi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 34% volume in CA
$16,802 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,638
Medicare services
Top 34% in CA for dermatology
1,982
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~202 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,147 | $6 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
682 | $67 | $200 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
313 | $45 | $154 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
252 | $92 | $265 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
237 | $74 | $246 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
236 | $1 | $2 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
142 | $77 | $236 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $43 | $126 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $96 | $281 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
86 | $11 | $32 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
83 | $138 | $389 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
78 | $50 | $161 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
40 | $43 | $116 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
34 | $38 | $130 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $113 | $364 |
| Destruction of skin growth, 15 or more growths | 17 | $105 | $307 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
16 | $105 | $287 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
12 | $273 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,802
Total received (2018-2024)
Avg $2,400/year across 7 years
Top 11% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
813
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,592 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,384
2023
$3,692
2022
$3,296
2021
$1,400
2020
$516
2019
$1,686
2018
$1,830
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$810
Janssen Biotech, Inc.
$577
Regeneron Healthcare Solutions, Inc.
$435
STRATA Skin Sciences, Inc.
$343
GENZYME CORPORATION
$318
LEO Pharma Inc.
$262
E.R. Squibb & Sons, L.L.C.
$250
Lilly USA, LLC
$246
Incyte Corporation
$241
SUN PHARMACEUTICAL INDUSTRIES INC.
$237
Novartis Pharmaceuticals Corporation
$198
Amgen Inc.
$107
PFIZER INC.
$104
Dermavant Sciences, Inc.
$63
UCB, Inc.
$60
Galderma Laboratories, L.P.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Almirall LLC
$23
MAYNE PHARMA COMMERCIAL LLC
$18
Arcutis Biotherapeutics, Inc.
$16
Top 3 companies account for 41.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,117
Janssen Biotech, Inc.
$1,943
LEO Pharma Inc.
$1,072
Regeneron Healthcare Solutions, Inc.
$1,063
Lilly USA, LLC
$1,000
GENZYME CORPORATION
$938
Incyte Corporation
$865
Novartis Pharmaceuticals Corporation
$623
Sun Pharmaceutical Industries Inc.
$605
PFIZER INC.
$559
Ortho Dermatologics, a division of Bausch Health US, LLC
$548
Galderma Laboratories, L.P.
$498
AbbVie Inc.
$453
UCB, Inc.
$433
STRATA Skin Sciences, Inc.
$428
AbbVie, Inc.
$422
EPI Health, LLC
$406
E.R. Squibb & Sons, L.L.C.
$389
Amgen Inc.
$308
SUN PHARMACEUTICAL INDUSTRIES INC.
$296
Almirall LLC
$284
DERMIRA, INC.
$174
Boehringer Ingelheim Pharmaceuticals, Inc.
$148
SANOFI-AVENTIS U.S. LLC
$120
Genentech USA, Inc.
$117
Dermavant Sciences, Inc.
$106
Celgene Corporation
$93
Stemline Therapeutics Inc.
$83
Mayne Pharma Inc.
$83
VYNE Pharmaceuticals Inc.
$74
Arcutis Biotherapeutics, Inc.
$72
Encore Dermatology Inc.
$72
Biofrontera Inc.
$69
Helsinn Therapeutics (U.S.), Inc.
$45
DUSA Pharmaceuticals, Inc.
$44
Journey Medical Corporation
$38
Aclaris Therapeutics, Inc.
$38
Allergan, Inc.
$33
Fresenius Kabi USA, LLC
$31
PruGen, Inc. Pharmaceuticals
$28
Taro Pharmaceuticals USA, Inc.
$23
MAYNE PHARMA COMMERCIAL LLC
$18
Merck Sharp & Dohme Corporation
$15
Verrica Pharmaceuticals Inc.
$15
Novum Pharma, LLC
$13
Top 3 companies account for 30.5% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Alcortin A · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · ELZONRIS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA EFINACONAZOLE · Klisyri · LIBTAYO · LITFULO · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Odomzo · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XTRAC · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
265
Per 100K population
13.9
County median income
$159,674
Nearest hospital
PALO ALTO VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Navi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Navi experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Navi performed 1,147 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Navi receive payments from pharmaceutical companies?
Yes. Dr. Navi received a total of $16,802 from 45 companies across 813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Navi's costs compare to other dermatologists in Palo Alto?
Dr. Navi's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Navi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Palo Alto
Browse dermatologists in Palo Alto ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology